Hepatitis A virus seroprevalence by age and world region, 1990 and 2005.

[1]  P. van Damme,et al.  Hepatitis A and E: update on prevention and epidemiology. , 2010, Vaccine.

[2]  G. Armstrong,et al.  The epidemiology of hepatitis A virus infections in four Pacific Island nations, 1995-2008. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[3]  M. Hacımustafaoğlu,et al.  Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations , 2008, Journal of viral hepatitis.

[4]  M. Vacchino.  Incidence of Hepatitis A in Argentina after vaccination , 2008, Journal of viral hepatitis.

[5]  P. van Damme,et al.  Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology , 2008, Journal of viral hepatitis.

[6]  G. Zhuang,et al.  A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China. , 2008, Vaccine.

[7]  H. Nothdurft.  Hepatitis A vaccines , 2008, Expert review of vaccines.

[8]  Anthony Fiore,et al.  Hepatitis A in the era of vaccination. , 2006, Epidemiologic reviews.

[9]  F. Souto,et al.  Epidemiological pattern and mortality rates for hepatitis A in Brazil, 1980-2002--a review. , 2006, Memorias do Instituto Oswaldo Cruz.

[10]  J S Koopman,et al.  The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. , 2005, International journal of epidemiology.

[11]  J S Koopman,et al.  Declining hepatitis A seroprevalence: a global review and analysis , 2004, Epidemiology and Infection.

[12]  F. Al-Faleh.  Changing pattern of hepatitis viral infection in Saudi Arabia in the last two decades. , 2003, Annals of Saudi medicine.

[13]  J. Cuthbert,et al.  Hepatitis A: Old and New , 2001, Clinical Microbiology Reviews.

[14]  M. Ciocca.  Clinical course and consequences of hepatitis A infection. , 2000, Vaccine.

[15]  A. Simjee,et al.  Racial differences in the seroprevalence of hepatitis A virus infection in Natal/KwaZulu, South Africa , 1994, Journal of medical virology.

[16]  C. Bauch,et al.  Cost-Effectiveness Analyses of Hepatitis A Vaccine , 2012, PharmacoEconomics.

[17]  J. Luyten,et al.  Costing Infectious Disease Outbreaks for Economic Evaluation , 2012, PharmacoEconomics.

[18]  Bianca Bruzzone,et al.  Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study , 2007, European Journal of Epidemiology.